1. 471PA phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study. (23rd October 2018) Authors: Suenaga, M; Wakatsuki, T; Ogura, M; Ichimura, T; Shinozaki, E; Nakayama, I; Osumi, H; Ota, Y; Chin, K; Mashima, T; Seimiya, H; Takahari, D; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗